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Abstract
The rat is a reference animal model for physiological studies and for the analysis of multigenic human diseases such as
hypertension, diabetes, neurological disorders, and cancer. The rats have long been used in extensive chemical
carcinogenesis studies. Thus, the rat embryonic stem (rES) cell is an important resource for the study of disease models.
Attempts to derive ES cells from various mammals, including the rat, have not succeeded. Here we have established two
independent rES cells from Wister rat blastocysts that have undifferentiated characters such as Nanog and Oct3/4 genes
expression and they have stage-specific embryonic antigen (SSEA) -1, -3, -4, and TRA-1-81 expression. The cells were
successfully cultured in an undifferentiated state and can be possible over 18 passages with maintaining more than 40% of
normal karyotype. Their pluripotent potential was confirmed by the differentiation into derivatives of the endoderm,
mesoderm, and ectoderm. Most importantly, the rES cells are capable of producing chimera rats. Therefore, we established
pluripotent rES cell lines that are widely used to produce genetically modified experimental rats for study of human
diseases.
Citation: Ueda S, Kawamata M, Teratani T, Shimizu T, Tamai Y, et al. (2008) Establishment of Rat Embryonic Stem Cells and Making of Chimera Rats. PLoS ONE 3(7):
e2800. doi:10.1371/journal.pone.0002800
Editor: Maarten M. S. van Lohuizen, Netherlands Cancer Institute, Netherlands
Received February 15, 2008; Accepted July 1, 2008; Published July 30, 2008
Copyright:  2008 Ueda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is supported by a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control, Health Science Research Grants for
Research on the Human Genome and Gene Therapy from the Ministry of Health, Labour and Welfare of Japan, a Grant-in-Aid for Scientific Research on Priority
Areas Cancer from the Ministry of Education, Culture, Sports, Science and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences
of the Organization for Pharmaceutical Safety and Research of Japan. S.U. and M.K. were awardees of Research Resident Fellowships from the Foundationf o r
Promotion of Cancer Research.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: tochiya@ncc.go.jp
Introduction
ES cells are derived from the inner cell mass (ICM) of
blastocysts and are capable of unlimited, undifferentiated prolif-
eration in vitro. Mouse ES cell (mES) lines were first established by
culturing ICM [1,2] in the presence of the feeder cell layer made
of mouse embryonic fibroblast (MEF) and leukemia inhibitory
factors (LIF) [3]. These cells have a stable developmental potential
to form derivatives of all three embryonic germ layers even after
prolonged culture [4], and have been used to study the mechanism
of cell differentiation. Moreover, they are capable of generating
germ-line chimeras following injection into the blastocyst [5].
Thus, the creation of targeted mutation in the mouse has been a
valuable source of animal models of human disease.
The rat is a reference animal model for physiological studies
and for the analysis of multigenic human diseases such as
hypertension, diabetes, and neurological disorders [6] and in
extensive chemical carcinogenesis studies, rats have been used for
a long period. Thus, rES cells are important resources for the
study of disease models.
Previously, attempts to establish a stable pluripotent ES cell line
from rats have been reported [7,8,9,10,11]. However, the develop-
mental potentials of these cell lines remain poorly characterized and
they have not yet been shown to reconstitute the germ line.
Here we have established rES cells that have all undifferentiated
characters, a stable long-term culture condition, maintain a
normal karyotype, maintain a pluripotent potential to differentiate
into derivatives of the endoderm, mesoderm, and ectoderm, and
most importantly, that are capable of producing chimeras.
Thus, our rES cells will provide a useful resource for the
development of large animal models for human disease,
regenerative medicine, and pharmaceutical research.
Results
Establishment and Maintenance of Rat ES Cell Lines
Zona-free blastocysts or morulae embryos (Figure 1A) were
cultured on a feeder layer for 2 or 3 days. As a result, total 42 ICM
showed enough growth to be subcultured in rES culture medium
(RESM) (Figure 1B). Rat LIF was not absolutely required during
the process of ICM growth. These ICM were dissociated into
clusters of cells. These clusters derived from some embryos were
mixed and transferred onto a new feeder layer for propagation,
because the cells needed to be high density to establish rES cell
lines. Several days after subculturing, colonies with highly
compacted cell clusters were picked up and transferred onto a
new feeder layer. rES cell lines were stably maintained by the bulk
passage method [12] using both collagenase treatment and
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The cells were typically subcultured every 3–4 days at a splitting
ratio of 1:3. After these procedures two independent ES cell lines
(Ws-4 and Ws-9) (Figures 1C and D, Figures S1A and B) were
isolated, successfully propagated and used for detailed analyses.
Ws-4 rES cells were maintained in the presence of rat LIF at
1000 U/ml up to passage 5 and then they were divided into three
groups: Ws-4-1 was cultured in the presence of 250 U/ml rat LIF;
Ws-4-2 was cultured in the presence of 500 U/ml rat LIF; Ws-4-3
was cultured in the presence of 1000 U/ml rat LIF. Ws-9 was
maintained without rat LIF. These cells grew flat and possessed a
similar morphology to the human and monkey ES cell lines
(Figures 1C and D, Figures S1A and B). They did not form domed
colonies, which are typical for mES cells. Ws-4-3 cells were not
used further analysis since they rapidly grew and easily lost their
stem cell-like phenotype.
Stem Cell Markers and Karyotype analysis of rES cells
To characterize the propertiesoftheisolatedcelllines,we analysed
alkaline phosphatase activity, SSEA-1, SSEA-3, SSEA-4, TRA-1-60,
TRA-1-81 and Nanog by immunostaining. Mouse ICM, EScellsand
EC cells express SSEA-1 but do not express SSEA-3 or SSEA-4. Ws-
4-2 rES cells expressed SSEA-1, SSEA-3, SSEA-4, TRA-1-81 and
Nanog at passage13 (Figures 1E–H and J). However, these cells were
negative for alkaline phosphatase activity (data not shown) and TRA-
1-60 (Figure 1I). Ws-9 rES cells expressed SSEA-1, SSEA-3, SSEA-4,
TRA-1-81 and Nanog at passage 12 (Figures S1C–F and H). Ws-9
rES cells were also negative for alkaline phosphatase activity (data not
shown) and TRA-1-60 (Figures S1G). Their summary was presented
in Table S1.
Next, we examined expression of several molecular markers by
real-time PCR analysis. Like Oct3/4, the expression of Nanog
mRNA is restricted to pluripotent stem cells and absent in
differentiated ones [13,14]. The Ws-4-1, Ws-4-2 and Ws-9 rES
cells expressed Nanog and Oct3/4 at passage 17 (Figure 1K).
Karyotype was assessed during the process of establishment and
long-term passage of rES cells. Chromosome number of each cell
line was counted as shown in Figure S2 and their summary was
presented in Table S2. The Ws-4-1, Ws-4-2, Ws-4-3 and Ws-9 rES
cells had more than 40% of normal karyotype at passage 11 to 18.
Differentiation Potency
EBs were produced by culturing rES cell aggregates in Petri
dishes. Ws-4-1 and Ws-9 rES cells formed simple EBs within a few
days (Figure 2A). Especially, when these cultures were maintained,
simple EBs of Ws-4-2 developed cystic EBs (Figure 2B).
To examine rES cell differentiative capacity in greater detail, we
determined whether rES cells could differentiate into a wide variety
of cell types in vitro. Generation of derivatives of the three germ
layers from Ws-4-1 was confirmed by the expression of markers
including beta-III tubulin (neuroectoderm) (Figure 2C), nestin
(Figure S3A), cytokeratin 18 (endoderm) (Figure 2D), alpha-smooth
muscle actin (SMA) (mesoderm) (Figure 2E) and CD31 (Figure
S3B). Ws-9 differentiated into ectoderm (beta-III tubulin, Figure
S3C) andendoderm(CK18,FigureS3D).Mesodermdifferentiation
from Ws-9 was not tested. Next, we transplanted the rES cells of the
Ws-4-1, Ws-4-2andWs-9 line respectively into theseverecombined
immunodeficient (SCID)-mice. Tumors formation was found after
5–16 weeks. Ws-4-1 formed tumors from all injections (subcutane-
ous injections: n=3, and intratesticular injection: n=1). Ws-4-2
formed a tumor from subcutaneous injection (n=1). Ws-9 formed
tumors from 3 subcutaneous injections (n=5) and from 2
intraperitoneal injections (n=6). The tumor in 6 weeks from Ws-
9 was shown (Figure 2F as subcutaneous tumors). These tumors
were consisted from two germ layers including an intestinal
epithelium-like structure (endoderm, Figure 2G), and a cartilage-
like structure (mesoderm, Figure 2H). An ectodermal origin
structure was not found in these tumors.
Making of Chimera Rats
Next, we examined the ability of rES cells to produce chimeras.
For this purpose, rES cell lines named Ws-4-1, Ws-4-2 and Ws-9
were used. We injected EGFP-positive rES cells (Figure S4B) into
Jcl:Wister rat derived blastocysts, which we then transplanted into
the uteri of pseudo-pregnant rats. We obtained total 11 pups born (7
alive and 4 dead) and 6 embryos (E18.5 or E15.5) from 351 injected
and transferred blastocysts using three independent cell lines
(Table 1). We examined the presence of chimera rats by PCR
analyses to know whether rES cells contributed to various organs.
This yielded 10 chimera rats (Figure 3 and Table 1). In 3 pups
derived from Ws-4-1 rES cells, PCR analysis detected rES cell
contribution in the liver, heart and skin (Figure S5A). In 4 live pups
from Ws-4-2 rES cells, PCR analysis detected rES cell contribution
in the blood cells, ears and tails (Figure 3B). We obtained 4 embryos
at E18.5 from Ws-4-1 and 2 embryos at E15.5 from Ws-4-2, and
PCR analysis detected rES cell contribution in 3 embryos (E18.5)
from Ws-4-1 (Figure S5B). The chimera rats derived from Ws-4-2
rES cells were grown and showed no abnormality (Figure 3A). In
rES cells of Ws-9 line, no chimera rat was obtained so far.
Discussion
Here, we show for the first time that we have established the
rES cells from a Wister rat blastocyst. Our rES cells have all
undifferentiated characters as follows: 1) a stable long-term culture
can be possible over 18 passages with maintaining more than 40%
of normal karyotype; 2) express ES cell-specific genes such as
Nanog and Oct3/4; 3) express SSEA-1, -3, -4, and TRA-1-81; 4)
maintain the pluripotent potential to differentiate into derivatives
of all three embryonic germ layers and are capable of producing
chimera rats. Thus, these results define our rES cells as an
embryonic stem cell line and will be routinely used to generate
targeted mutations, conditional knockout and gene replacement,
which are required to produce relevant large animal models for
human physiology, disease, regenerative medicine, and pharma-
ceutical research.
We established and characterized two independent ES cell lines.
Interestingly, the morphology of rES was similar to primate ES
cells reported so far and the cells formed flatter colonies than the
typical domed colonies of mES cells. Similar to primate ES cells,
rES cells exhibited a very low plating efficiency when dissociated
into single cells.
Figure 1. Generation of rat ES cells and expression of stem cell markers. Frozen Jcl:Wister blastocysts were treated in tyrode’s Solution. (B)
ICM derived cells attached to MEFs after 3 days of blastocyst culture and (C and D) Ws-4 colonies at passage 8. Scale bar, 200 mm. Expression of cell
surface markers by Ws-4-2 cells at passage 13. (E) Nanog, (F) SSEA-1, (G) SSEA-3, (H) SSEA-4 and (J) TRA-1-81 were positive. (I) TRA-1-60 was negative.
Scale bar, 100 mm. (K) Nanog and Oct-3/4 expression analysis of rES cells. Transcript levels were normalized to rat GAPDH expression, with expression
levels MEFs set as 1.0. Real-time PCR analysis of Ws-4-1 p17, Ws-4-2 p17, Ws-9 p17, MEFs and mES (derived from 129sv). Nanog (Left) and Oct-3/4
(Right) were detected in all rES cell lines; however, each rES cell lines shows different expression levels.
doi:10.1371/journal.pone.0002800.g001
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cells were greatly reduced by replacement of FBS with KSR [15].
Furthermore, bFGF was reported to increase the cloning efficiency
of human ES (hES) cells [16]. However, rES cells were not
established and there were slower growth rates in the KSR
medium than in the FBS medium with or without rat bFGF.
Maintenance ofthe undifferentiated state and pluripotency inmES
cells requires the presence of MEF feeder layers or LIF. LIF is known
to bind to its receptor, LIFR, which heterodimerizes with the signal-
transducing receptor gp130. The pluripotency of mES depends on
the intracellular signaling events that follow, including phosphoryla-
tion by the Janus family of tyrosine kinases (JAK), which leads to
activation of the signal transducer protein STAT3 [17]. LIFR, IL6R
and gp130 were expressed on hES cells, and, when stimulated with
either LIF or IL-6, activated STAT3. However, augmented levels of
gp130-stimulated STAT3 activation failed to maintain hES cells in
the undifferentiated state, with the progressive loss of TRA-1-60,
Nanog, and Oct4 expression [18]. LIFR was expressed on our rES
cells (Figure S6). We cloned complete rat LIF cDNA and determined
t h en u c l e o t i d es e q u e n c e[ 1 9 ]b e c a u s eo ft h ef a i l u r eo fr e c o m b i n a n t
mouse LIF to keep the pluripotent phenotype of rES cells long term.
Although rat LIF was not necessary to ICM growth and its
expansion, rat LIF was important to keep the expression levels of
Nanog as an equivalent to mES cells. Nanog was expressed at lower
levels in line Ws-4-1 (250 U/ml rat LIF) and Ws-9 (0 U/ml rat LIF)
than in mES cells. It is reported that a 50% increase or decrease in
Oct3/4 proteins induces differentiation of ES cells [20]. Oct3/4
expression was dramatically increased in Ws-4-1 and decreased in
Ws-9. These data suggest that rat LIF is useful for maintenance of the
undifferentiated state and pluripotency in rES cells for a long-term
period.
When mES cells are grown in a serum-free medium, BMP4 and
LIF can indeed support ES cell line derivation, maintenance of
pluripotency, chimera colonization and germline transmission
properties [21]. We found the BMP4 receptor expressed on rES
cells (Figure S6). We examined whether the addition of rat LIF
and human BMP4 might contribute to self-renewal and an
inhibition of differentiation of rES cells. Ws-9 was maintained
without rat LIF. Ws-9 cells were plated on MEFs in the rES
medium with rat LIF (500 U/ml), human BMP4 (10 ng/ml) or rat
LIF plus human BMP4. After day 4 and day 8, rES cell status was
confirmed by expression of mRNAs for ES cell specific
Figure 2. Pluripotency of rat ES cells. Embryoid bodies formation (A) Ws-4-1and (B) Ws-4-2. Scale bar, 200 mm. Immunostaining confirming in
vitro differentiation into all three germ layers (Ws-4-1). Expression of (C) beta-III tubulin (ectoderm), (D) cytokeratin 18 (endoderm) and (E) alpha-SMA
(mesoderm). Scale bar, 50 mm. (F) Ws-9 derived tumor after subcutaneous injection into SCID-mouse. Hematoxylin and eosin stained histological
sections of rES (Ws-9) derived tumor: (G) intestinal epithelium-like structure (endoderm) and (H) cartilage-like structure (mesoderm).
doi:10.1371/journal.pone.0002800.g002
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significant induction of Oct3/4 expression in the presence of rat
LIF alone as well as rat LIF plus BMP4 at day 8 in culture (Figure
S7). In contrast, Sox2 expression was reduced by rat LIF alone as
well as rat LIF plus human BMP4. Nanog expression was not
increased by rat LIF, human BMP4 or rat LIF plus human BMP4.
These data suggest that 500 U/ml of rat LIF and 10 ng/ml of
human BMP4 are not sufficient to maintain our rES cells for an
expression of Oct3/4, Nanog and Sox2.
Our rES cells expressed some stem cell markers. However,
expression patterns of SSEA antigens in some species are different.
The expression patterns of SSEA antigens in rat EC cells and ICM
cells are not well documented. Ws-9 was negative for SSEA-1 and
TRA-1-81 and stained weakly for Nanog at passage 30, but
retained expression of SSEA-3 (data not shown). These results
suggest that differentiated cells stained for SSEA-3.
Oct3/4, Sox2, and Nanog have been shown to function as core
transcription factors in maintaining pluripotency [22,23]. rES cells
expressed Oct3/4 and Nanog. Curiously, alkaline phosphatase
activity, which generally marks pluripotent cells was present in
hES cells and mES cells, but disappeared abruptly upon culture
and was undetectable in rES cells. Alkaline phosphatase activity
persists in primordial germ cells [24,25] in the gastrulating embryo
[26] and in their in vitro derivatives, the embryonic germ cells.
Genes associated with the germ line, including Stella, Piwil2, Stra8
and Dazl were expressed by mES cells and significantly decreased
or were not detected in hES cells. Stella and Piwil2 were not
increased in rES cells by microarray analyses (Figure S8B).
However, the rES cells expressed Vasa (Figure S6), which is present
in fetal and adult gonadal germ cells in both males and females
and is most abundant in spermatocytes and mature oocytes
[27,28]. These data suggest that rES cells might have a
differentiating ability to germ cell lineage.
Our rES cell lines had a normal number of chromosomes at
early passages, but lead to the rapid accumulation of chromosomal
abnormalities in late passages. High rates of aneuploidy are known
to be observed in hES cells during passage in culture. In particular,
trypsin-based solutions tend to cause over-dissociation of ES cells
into single cells, and this may promote karyotypic abnormalities
[29]. Previously, we succeeded in establishing rES cell lines from
Wistar Hannover GALAS rat. The resulting Wistar Hannover
GALAS rES cells had undifferentiated characters; however, these
cells developed karyotypic abnormalities during passage in culture
using trypsin (data not shown). These abnormalities are associated
with a decreased capacity of the cells for germ line colonization in
chimeras obtained after blastocyst injection [30,31]. However, it is
reported that karyotype and in vitro differentiating ability of mES
cells influence their germ-line contribution in chimeric mice. That
both exhibit approximately 40% of normal karyotype and show
cystic EBs formation within 7 days after suspension culture is a
possible indication of their germ-line transmitting ability in
chimeric mice [32]. In our rES cells, Ws-4-1, Ws-4-2 at 11 to
13 passages and Ws-9 cell lines at 18 passages retained more than
40% of normal karyotype and all they formed EBs within a few
days, indicating that they have a potency to contribute germ-line
transmission. In fact, our rES cells differentiated into three germ
layers in vitro: neurons, epithelial cells and smooth muscle cells.
Examination of tissue differentiation in teratomas produced from
rES cells revealed more wide differentiation potency.
Our rES cells can contribute to chimera formation when
injected into blastocysts. For further analysis of germline
transmission, 4 live chimeras derived from Ws-4-2 were mated
with normal males or females. Because rES cells do not survive
well as single cells, we examined their potential to contribute to
embryogenesis through diploid (4,16-cell, n=54) aggregation
and tetraploid (2,8-cell, n=38) aggregation using rES cell line
Ws-9. When rES cells were aggregated with diploid or tetraploid
and transferred to oviducts of recipient females, we obtained no
pups (data not shown). To test a developmental potency, 89 zona-
free 2-cell without rES cells were cultured for 3 days and
transferred to oviducts of recipient females. But no pups were
obtained. These results suggest that rat zona-free embryos cultured
in vitro are able to develop to blastocyst stage; however,
postimplantation development is incomplete. Aggregation meth-
ods may not be suitable for making chimera rats.
Recently, pluripotent stem cells were derived from the late
epiblast layer of post-implantation (EpiSCs) mouse and rat
embryos [33,34]. They seem to correspond very closely to human
rather than mES cells. The only exception is that EpiSCs lack
alkaline phosphatase activity. They are LIF and BMP4-indepen-
dent and require instead activin/nodal and FGF for efficient self-
renewal. EpiSCs can contribute poorly to chimeras after blastocyst
injection, but germline transmission was not observed. EpiSCs
provide a valuable experimental system for determining whether
Figure 3. Contribution of rES cells to chimeras. (A) Live chimera
rats derived from rES cells (Ws-4-2) were obtained. (B) Four chimeric rats
were obtained from 2 pseudopregnant rats by genotyping of blood
cells, ears and tails.
doi:10.1371/journal.pone.0002800.g003
Table 1. Efficiency of making of chimera rats from rES cells.
Injected
Blastocysts Pups*
No.of Screened
Pups Chimera
Ws-9 122 2 1 0
Ws-4-1 110 4 3 3
4 (E18.5) 4 3
Ws-4-2 119 5 5 4
2 (E15.5) 2 0
*Live pups, dead pups and developmentally abnormal embryos were included
in ‘‘Pups.’’
doi:10.1371/journal.pone.0002800.t001
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differences or diverse temporal origins. The rES cells, which
derived from ICM, have a morphology similar to hES cells. The
rES cells are likely to improve our understanding of the differences
between mouse and rat. To further characterize our rES cells, the
pattern of gene expression in two dependent lines of rES cells and
mES cells was assessed by whole genome expression arrays. As a
result, whole genome cluster analysis was performed by sorting of
3943 altered genes. The expression level of each gene in the MMC
treated MEF (for mES cells) or MMC treated rat embryonic
fibroblast (REF: for rES cells) sample was set to 1.0. Cluster
analysis showed that independently derived rES lines were similar
(correlation coefficients: 0.95795) and distinct from mES cells
(correlation coefficients: 0.12554)(Figure S8A). To validate the
results of the microarray analysis, we focused on several genes
associated with ICM, mES, EpiSC, hES [34]. Our data show that
the expression level of up-regulated genes in mES cells such as
cdh1/E-cadherin, Otx2, Cldn6, Nodal, Sox17, Foxa2, Acvr2b, Pitx2 and
Dkk1 were also up-regulated in our rES cells. On the other hand,
our data show that the genes significantly increased in mES cells
such as Dppa3/Stella, Fbxo15, Lefty2, Nr01/Dax1 and Sox2 were
slightly or not increased in rES cells (Figure S8B and Table S3).
Thus, microarray analysis shows that the gene expression profile of
our rES cells partially resembles mES cells. Furthermore, using a
database (GEO accession number GSE7902), the expression
pattern of rES cells was compared with that of mES cells and
EpiSCs [34]. The cluster analyses of rES cells, mES cells and
EpiSCs were performed by sorting 2866 altered genes common to
rat and mouse. Cluster analysis by sorting 2866 altered genes
showed that independently derived rES lines were similar
(correlation coefficients: 0.80782). Cluster analysis showed that
EpiSCs were not similar to mES cells (correlation coefficients:
0.42110) and distinct from rES cells (correlation coefficients:
0.22710). The cluster analysis of mES cells using a database
showed that mES cells were not similar to rES cells (correlation
coefficients: 0.36524) (data not shown).
In this report, we have established rES cell lines that maintain a
pluripotent potential and a normal number of chromosomes. And
we have obtained chimera rats derived from rES cells by
genotyping. The ability of these cells to give rise to germline
transmission is currently under investigation. Our results pave the
way for more extensive genetic modifications such as conditional
knock-out and gene replacement, which are required to produce
relevant models of human diseases.
Materials and Methods
Rat ES medium
Rat ES culture medium (RESM) consisted of 1:1 mixture of
Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s
nutrient mixture F-12 (DMEM/F-12, Gibco) supplemented with
3% fetal bovine serum (Gibco), 0.1 mM 2-mercaptoethanol
(Sigma), 1% nonessential amino acid stock (Gibco), 2 mM L-
glutamine (Gibco), 1 mM sodium pyruvate (Gibco), 16antibiotic-
antimycotic (Gibco), 16 nucleoside stock (Sigma) (1006: Adeno-
sine (0.8 mg/ml), Guanosine (0.85 mg/ml), Cytidine (0.73 mg/
ml) Uridine (0.73 mg/ml) and Thymidine (0.24 mg/ml)).
Establishment and Maintenance of Rat ES Cell Lines
Frozen Jcl:Wister embryos were prepared by CLEA Japan, Inc.
Blastocysts (n=37) and morulae (n=14) were treated in tyrode’s
Solution (Ark Resource Co. Ltd.) and washed with Quinn’s
Advantage Blastocyst Medium (SAGE In-Vitro Fertilization, Inc.
A Cooper Surgical Company) with 3% KSR (Gibco) added. Seven
to ten zona-free embryos per 60 mm dish were placed on mouse
embryonic fibroblasts inactivated with mitomycin C (MEFs,
Millipore) in RESM. After 2 or 3 days, ICM-derived cells were
dissociated into clumps by exposure to 0.025% trypsin (cell line
Ws-4) or 0.05% collagenase type IV (Gibco) in DMEM/F-12 and
mechanical dissociation (cell line Ws-9) with a Stem Cell Cutting
Tool (SWEMED Lab International AB; Billdal, Sweden), before
transfer onto a new feeder layer. Colonies with stem cell-like
morphology were picked up, dissociated with 0.05% collagenase
type IV and dissociated mechanically, and transferred to a feeder
layer for expansion. Once established, rES cells were routinely
passaged every 3–4 days up to 5 passages in RESM in the presence
of rat LIF (Millipore/Chemicon International) at 1000 U/ml, and
then they were cultured in RESM supplemented with 250 U/ml,
500 U/ml or 1000 U/ml rat LIF (Ws-4 rES cell line) or without
rat LIF (Ws-9 rES cell line). Counting of the chromosome number
was carried out at passage 10 to 18.
Histochemical Analysis of the Stem Cell Markers
Alkaline phosphatase activity was detected with Vector Blue
substrate (Vector Labs). SSEA-1, SSEA-3, SSEA-4, TRA-1-60,
TRA-1-81 (Millipore) and Nanog (ReproCELL, Japan) were
detected by immunocytochemistry. Cells were fixed in 4%
paraformaldehyde, then incubated for 1 hour in blocking solution
(image iT, Invitrogen). Primary antibodies applied for overnight at
4uC. Secondary antibodies conjugated to Alexa fluorophores
(Molecular Probe) at 1:1000 dilution were incubated with cells for
1.5 hours at room temperature.
Real-time-PCR
Total RNA was isolated using the ISOGEN (Nippongene,
Tokyo, Japan) and samples were treated with DNase I (Takara).
The cDNA was made from 2 mg of total RNA using Super Script
III RT (Invitrogen) and oligo-dT primers (Invitrogen).
cDNAs were used for PCR using Platinum SYBR Green qPCR
SuperMix UDG (Invitrogen). Optimization of the qRT-PCR
reaction was performed according to the manufacture’s instructions
(PE Applied Biosystems, Tokyo, Japan). All quantitations were
normalized to an endogeneous control GAPDH. Relative gene
induction values were calculated according to the manufacture’s
instructions. The following primers were used: Nanog, forward, 59-
GCCCTGATTCTTCTAGCAAT-39 and reverse, 59-AGAACA-
CAGTCCGCATCTT-39; Oct3/4, forward, 59-CATCTGCCG-
CTTCGAG-39 and reverse, 59-CTCAATGCTAGTCCG-
CTTTC-39;r a tGapdh,f o r w a r d ,5 9-TTCAACGGCACAGT-
CAAGG-39 and reverse, 59-CATGGACTGTGGTCATGAG-39.
Analysis of Differentiation Potency
The developmental potential of rES cells was assessed in vitro by
forming EBs. rES cell colonies were harvested with collagenase IV,
gently triturated, and cultured for 5–10 days in suspension culture
dishes (Zarstat) containing RESM without rat LIF.
For differentiation of rES cells into neural lineages, the EBs
were maintained for 2–3 days in RESM without rat LIF and for 3–
4 days in RESM with 10
26 M retinoic acid (Sigma). EBs were
treated with 0.25% trypsin-EDTA. Dispersed cells were collected
by centrifugation and replated on poly-L-ornithin (Sigma)-coated
4 well Lab Tech II chamber slides (BD) in B27 medium (DMEM/
F12 [1:1] supplemented with B27 supplement (Invitrogen), 5 mM
HEPES buffer (Sigma), 2 mg/ml heparin (Sigma), antibiotic-
antimycotic (Invitrogen) and 1% FBS.
For differentiation of rES cells into endoderm and mesoderm,
rES cells were cultured in the absence of MEFs on a gelatin coated
plate in RESM without rat LIF.
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saline (PBS) for 20 min at room temperature. Fixed cells were
blocked for 1 hr at room temperature with PBS/0.1% BSA/10%
normal goat serum/0.3% Triton X-100 for beta-III tubulin and
alpha-SMA or PBS/0.1% BSA/10% normal goat serum for
cytokeratin 18 (CK18) then incubated overnight with anti-beta-III
tubulin (COVANCE) at 1:2000, anti-alpha-SMA (SIGMA) at
1:1000 or anti-CK18 antibody (Millipore) at 1:50. Secondary
antibodies conjugated to Alexa fluorophores (Molecular Probe) at
1:1000 dilution were incubated with cells for 1.5 hours at room
temperature. Stained cells were analysed using HS All-in-one
Flourescence Microscope (KEYENCE Corporation, Japan) and
ECLIPSE TE300 (Nikon Corporation, Japan).
The rES cells were also tested for their ability to form teratomas.
Approximately 10
7 rES cells were injected subcutaneously or 10
6–
8610
6 rES cells were injected intratesticulally or intraperitoneally
into the C.B17/Icr-scid (scid/scid) mice (CLEA Japan, Inc.).
Teratomas were excised when tumor formation become outwardly
apparent. They were fixed in phosphate-buffered 10% formalin or
acetone. And they were processed for paraffin embedding for
histological observation.
Animal experiments in the present study were performed in
compliance with the guidelines of the Institute for Laboratory
Animal Research, National Cancer Center Research Institute.
Lentivirus Transduction to ES Cells
Lentivirus-green fluorescent protein (LV-GFP), which carries
the expression cassette for eGFP, was constructed with pLenti6
(Invitrogen). rES cells were infected with LV-GFP at an moi of 250
or 500 for overnight in a volume of 500 ml. EGFP positive colonies
were selected and cultured on a new feeder layer.
Blastocyst Injection
The blastocysts were recovered from the uterus of natural
mated Jcl:Wister females at 4.5 days post coitum (d.p.c.). The
blastocysts were placed in a drop of HEPES (Nakamedical) under
mineral oil. rES cells were injected into the blastocyst cavity using
a microinjection pipette. After injection, blastocysts were returned
to mW medium (Mitsubishi Kagaku Iatron, Inc.) and placed at
37uC until transferred to recipient females. From 14 to 21 injected
blastocysts were transferred to each uterine horn of 4.5 d.p.c. of
pseudo-pregnant Jcl:Wister rats. In total, Ws-4-1, Ws-4-2, and Ws-
9 rES cells were injected into 351 blastocysts and they were
subjected to uterine transfer.
Genotyping
Offspring were screened for the presence of the EGFP gene by
PCR. Blood cells, ear and tail of pups and each tissue of neonates
killed at 15.5 or 18.5 d.p.c. were lysed in 50 mM Tris-HCl,
pH 8.2, containing 25 mM EDTA, 0.5% SDS, 10 mM NaCl and
1 mg/ml proteinase K. PCR was performed with the following
conditions: EGFP, 95uC3 0s ,5 8 uC3 0s ,7 2 uC 20 s (40 cycles) and
GAPDH, 95uC3 0s ,6 0 uC3 0s ,7 2 uC 30 s (25 cycles). Primers
were EGFP, forward, 59-CTGACCCTGAAGTTCATCTG-39
and reverse, 59-TCCTTGAAGTCGATGCCCTT-39; rat Gapdh,
forward, 59-TTCAACGGCACAGTCAAGG-39 and reverse, 59-
CATGGACTGTGGTCATGAG-39.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0002800.s001 (0.04 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0002800.s002 (0.03 MB
DOC)
Table S3
Found at: doi:10.1371/journal.pone.0002800.s003 (0.07 MB
DOC)
Figure S1 Generation of rat ES cells and expression of stem cell
markers. (A and B) Ws-9 colonies at passage 11. Scale bar, 200 mm
Expression of cell surface markers by Ws-9 cells at passage 12. (C)
Nanog, (D) SSEA-1, (E) SSEA-3, (F) SSEA-4 and (H) TRA-1-81
were positive. (G) TRA-1-60 was negative. Scale Bar, 50 mm
Found at: doi:10.1371/journal.pone.0002800.s004 (1.56 MB TIF)
Figure S2 The Ws-4-2 rES cell lines had a normal number of
chromosomes.
Found at: doi:10.1371/journal.pone.0002800.s005 (1.56 MB TIF)
Figure S3 The rES cells could differentiate into a wide variety of
cell types in vitro. Immunostaining confirming in vitro differen-
tiation. Expression of (A) nestin (ectoderm) and (B) CD31
(mesoderm) were observed in differentiated Ws-4-1. Expression
of (C) b-III tubulin (ectoderm) and (D) CK18 (endoderm) were
observed in differentiated Ws-9.
Found at: doi:10.1371/journal.pone.0002800.s006 (1.56 MB TIF)
Figure S4 rES cells transducted by LV-GFP. (A and B) EGFP
positive colonies (line Ws-9) were picked up and injected into the
blastosysts. (C and D) Cystic EBs were produced by EGFP positive
Ws-9 cells. Scale Bar: 100 mm. (E and F) EGFP positive rES (line
Ws-9) produced tumors after intraperitoneal injection.
Found at: doi:10.1371/journal.pone.0002800.s007 (1.56 MB TIF)
Figure S5 Contribution of rES cells (Ws-4-1 and Ws-9) by
genotyping. (A) Three chimeric rats were obtained from Ws-4-1
and no chimeric rat was obtained from Ws-9. (B) Three chimeric
embryos (E18.5) were obtained from Ws-4-1. pCAG-EGFP is a
vector with EGFP gene, positive control.
Found at: doi:10.1371/journal.pone.0002800.s008 (1.56 MB TIF)
Figure S6 RT-PCR analysis of rat Lifr and Vasa gene
expression in rES cells. Total RNA was isolated using the
ISOGEN (Nippongene, Tokyo, Japan) and samples were treated
with DNase I (Takara). cDNA was made from 2 mg of total RNA
using Super Script III RT (Invitrogen) and oligo-dT primers
(Invitrogen). cDNA was amplified with TaKaRa Ex Taq Hot Start
Version (Takara, Japan) using gene specific primers. The following
primers were used: rat Lifr, forward, 59-
CTGTCATTGTTGGCGTGGTA-39 and reverse, 59-GATTC-
CAGGACTTCGACGTG-39, 30 cycles; rat Vasa, forward, 59-
TTGGGCACTCAATTCGAC-39 and reverse, 59-AACTTCTT-
CATTTCGGGTCC-39, 32 cycles; rat Bmpr1a, forward, 59-
CCATTTCCAGCCCTACATCA-39 and reverse, 59-
TTCCAGCGGTTAGAGACGAT-39, 35 cycles.
Found at: doi:10.1371/journal.pone.0002800.s009 (1.56 MB TIF)
Figure S7 Oct3/4 and Sox2 expression analysis of rES cells in
response to LIF, BMP4, or LIF plus BMP4. Ws-9 was maintained
without rat LIF. The 5610
4/well of Ws-9 cells were plated on
MEFs of gelatin coated 6 well plates in the RESM. Culture
condition was divided into four groups 1) rat LIF (-) and human
BMP4 (-), 2) rat LIF (-) and human BMP4 (10 ng/ml), 3) rat LIF
(500 U/ml) and human BMP4 (-), 4) rat LIF (500 U/ml) and
human BMP4 (10 ng/ml). After day 4, rES cells were passaged
5610
4/well. Real-time PCR analysis of Ws-9 p14 (day 4), p15 (day
8) and MEFs. cDNAs were used for PCR using Platinum SYBR
Green qPCR SuperMix UDG (Invitrogen). Optimization of the
Establishment of Rat ES Cells
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instructions (PE Applied Biosystems, Tokyo, Japan). The following
primers were used: Oct3/4, forward, 59-CATCTGCCGCTTC-
GAG-39 and reverse, 59-CTCAATGCTAGTCCGCTTTC-39;
Sox2, forward, 59-CCCACCTACAGCATGTCCTA-39 and re-
verse, 59-TGGAGTGGGAGGAAGAGGTA-39; rat Gapdh, for-
ward, 59-TTCAACGGCACAGTCAAGG-39 and reverse, 59-
CATGGACTGTGGTCATGAG-39. Transcript levels were nor-
malized to rat GAPDH expression, and expression levels of rES
cell cultured without rat LIF and human BMP4 at day 4 set to 1.0.
The results present the mean of two real-time PCR analysis.
Oct3/4 (Red) expression was increased in rat LIF and rat LIF +
human BMP4, however, Sox2 (Blue) expression was not increased.
Found at: doi:10.1371/journal.pone.0002800.s010 (1.56 MB TIF)
Figure S8 Microarray analysis and hierarchical clustering
analysis. A one-color microarray-based gene expression analysis
system (Agilent Technologies, Santa Clara, CA) containing 41,000
genes was used, following the manufacturer’s instructions. Total
RNA was extracted from MMC treated MEF, mES cells (derived
from 129sv, p6), MMC treated rat embryonic fibroblast (REF,
3Y1-B,p5) [19], Ws-4-2 (p17), Ws-4-2 (p14) and Ws-9 (p17). The
process of hybridization and washing was performed using a Gene
Expression Wash Pack (Agilent Technologies) and acetonitrile
(Sigma, Tokyo, Japan). A DNA microarray scanner (Agilent
Technologies) was used for array scanning. Data normalization
and cluster analysis were performed using GeneSpring GX
software (Agilent Technologies). The expression level of each
gene in the MMC treated MEF (for mES cells) or MMC treated
REF (for rES cells) was used as a reference. Microarray data of
mouse and rat was integrated via GeneSymbol, and omitted
missing values. This resulted in a data matrix of 3943 genes. A
hierarchical cluster was produced using an Euclidean distance
calculation based on the Ward method calculation. (A) Cluster
analysis was performed by sorting 3943 altered genes. Red
indicates increased expression compared to levels of MMC treated
MEF or MMC treated REF, whereas green means decreased
expression. Correlation coefficients are indicated. This analysis of
microarray data shows that there are distinct gene clusters between
rES cells and mES cells. (B) The expression of genes to maintain
the pluripotent state of mES cells or EpiSCs or hES cells. Gene
names shown in red were detected in hES cell cultures and EpiSC
using Illumina and Agilent whole-genome microarrays [34]. This
microarray analysis shows that the gene expression profile of our
rES cells partially resembles mES cells.
Found at: doi:10.1371/journal.pone.0002800.s011 (1.56 MB TIF)
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